Delayed visual NA potential in remitted schizophrenia: A new vulnerability marker for psychotic relapse under low-dose medication

Biological Psychiatry

Volumn 45, Issue 1, 1999, Pages 107-115

  Matsuoka, Hiroo ^a   Matsumoto, Kazunori ^a   Yamazaki, Hisato ^a   Yoshida, Sumiko ^a   Numachi, Yohtaro ^a   Saito, Hidemitsu ^c   Ueno, Takashi ^b   Sato, Mitsumoto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c National Hospital Organization Hanamaki Hospital   (Japan)

Author keywords

Event related potential; NA potential; Psychotic relapse; Schizophrenia; Vulnerability

Indexed keywords

BROMPERIDOL; CHLORPROMAZINE; HALOPERIDOL; LEVOMEPROMAZINE; THIORIDAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; SCHIZOPHRENIA; TASK PERFORMANCE;

ADULT; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032967993     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00526-X     Document Type: Article

References (47)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. 1987;American Psychiatric Press, Washington, DC.
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms. 1981;Department of Psychiatry, University of Iowa College of Medicine, Iowa City, IA.
3. Andreasen N.C. Scale for the Assessment of Positive Symptoms. 1984;Department of Psychiatry, University of Iowa College of Medicine, Iowa City, IA.
4. Baddeley A. Working Memory. 1986;Oxford University Press, New York.
5. Bleuler M. The Schizophrenic Disorders Long-Term Patient and Family Studies . 1978;Yale University Press, New Haven, CT.
6. Carpenter W.T. Jr, Heinrichs D.W., Wagman A.M.I. Deficit and nondeficit forms of schizophrenia The concept . Am J Psychiatry. 145:1988;578-583.
7. Ciompi L., Müller C. Lebensweg und Alter Schizophrener. Eine katamnestische Langzeitstudie bis ins Alter. 1976;Springer-Verlag, Berlin.
8. Crow T.J. Molecular pathology of schizophrenia More than one disease process? Br Med J. 280:1980;66-86.
9. Davis J.M. Overview Maintenance therapy in psychiatry: I. Schizophrenia . Am J Psychiatry. 132:1975;1237-1245.
10. Desmedt J.E. P300 in serial tasks An essential postdecision closure mechanism . Kornhuber H.H., Deecke L. Motivation, Motor and Sensory Processes of the Brain Electrical Potentials, Behaviour and Clinical Use . 1986;682-686 Elsevier, Amsterdam.
11. Duncan C.C., Morihisa J., Fawcett R.W., Kirch D.G. P300 in schizophrenia State or trait marker? Psychopharmacol Bull. 23:1987;497-501.
12. Ford J.M., White P.M., Csernansky J.G., Faustman W.O., Roth W.T., Pfefferbaum A. ERPs in schizophrenia Effects of antipsychotic medication . Biol Psychiatry. 36:1994;153-170.
13. Friedman D. Endogenous scalp-recorded brain potentials in schizophrenia A methodological review . Steinhauer S.R., Gruzelier J.H., Zubin J. Handbook of Schizophrenia, Volume 5 Neuropsychology, Psychophysiology and Information Processing . 1991;91-127 Elsevier, Amsterdam.
14. Goldman-Rakic P.S. Prefrontal cortical dysfunction in schizophrenia The relevance of working memory . Carroll B.J., Barrett J.E. Psychopathology and the Brain. 1991;1-24 Raven Press, New York.
15. Harding C.M., Brooks G.W., Ashikaga T., Strauss J.S., Breier A. The Vermont longitudinal study of persons with severe mental illness I. Methodology, study sample, and overall status 32 years later . Am J Psychiatry. 144:1987;718-726.
16. Harding C.M., Brooks G.W., Ashikaga T., Strauss J.S., Breier A. The Vermont longitudinal study of persons with severe mental illness II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia . Am J Psychiatry. 144:1987;727-735.
17. Hogarty G.E., Goldberg S.C., Schooler N.R., Ulrich R.F. Drug and sociotherapy in the aftercare of schizophrenic patients II. Two-year relapse rates . Arch Gen Psychiatry. 31:1974;603-608.
18. Holzman P.S. Recent studies of psychophysiology in schizophrenia. Schizophr Bull. 13:1987;49-75.
19. Huber G., Gross G., Schüttler R. A long-term follow-up study of schizophrenia Psychiatric course of illness and prognosis . Acta Psychiatr Scand. 52:1975;49-57.
20. Huber G., Gross G., Schüttler R., Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull. 6:1980;592-605.
21. Javitt D.C., Doneshka P., Zylberman I., Ritter W., Vaughan H.G. Jr. Impairment of early cortical processing in schizophrenia An event-related potential confirmation study . Biol Psychiatry. 33:1993;513-519.
22. Javitt D.C., Doneshka P., Grochowski S., Ritter W. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Arch Gen Psychiatry. 52:1995;550-558.
23. Johnson R. Jr. A triarchic model of P300 amplitude. Psychophysiology. 23:1986;367-384.
24. Kane J.M. Treatment of schizophrenia. Schizophr Bull. 13:1987;133-156.
25. Kissling W. Ideal and reality of neuroleptic relapse prevention. Br J Psychiatry. 161:(suppl 18):1992;133-139.
26. Lovrich D., Simson R., Vaughan H.G. Jr, Ritter W. Topography of visual event-related potentials during geometric and phonetic discriminations. Electroencephalogr Clin Neurophysiol. 65:1986;1-12.
27. Lukoff D., Liberman R.P., Nuechterlein K.H. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull. 12:1986;579-593.
28. Matsuoka H., Saito H., Ueno T., Sato M. Altered endogenous negativities of visual event-related potential in remitted schizophrenia. Electroencephalogr Clin Neurophysiol. 100:1996;18-24.
29. Näätänen R., Picton T.W. N2 and automatic versus controlled processes. Electroencephalogr Clin Neurophysiol Suppl. 38:1986;169-186.
30. Nuechterlein K.H., Dawson M.E. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull. 10:1984;300-312.
31. Nuechterlein K.H., Dawson M.E., Gitlin M., Ventura J., Goldstein M.J., Snyder K.S., et al. Developmental processes in schizophrenic disorders Longitudinal studies of vulnerability and stress . Schizophr Bull. 18:1992;387-425.
32. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol Rep. 10:1962;799-812.
33. Pritchard W.S. Cognitive event-related potential correlates of schizophrenia. Psychol Bull. 100:1986;43-66.
34. Ritter W., Simson R., Vaughan H.G. Jr, Macht M. Manipulation of event-related potential manifestations of information processing stages. Science. 218:1982;909-911.
35. Ritter W., Simson R., Vaughan H.G. Jr. Event-related potential correlates of two stages of information processing in physical and semantic discrimination tasks. Psychophysiology. 20:1983;168-179.
36. Ritter W., Ford J.M., Gaillard A.W.K., Harter M.R., Kutas M., Näätänen R., et al. Cognition and event-related potentials I. The relation of negative potentials and cognitive process . Ann NY Acad Sci. 425:1984;24-38.
37. Ritter W., Simson R., Vaughan H.G. Jr. Effects of the amount of stimulus information processed on negative event-related potentials. Electroencephalogr Clin Neurophysiol. 69:1988;244-258.
38. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry. 52:1995;805-818.
39. Shelley A.M., Ward P.B., Catts S.V., Michie P.T., Andrews S., McConaghy N. Mismatch negativity An index of preattentive processing deficit in schizophrenia . Biol Psychiatry. 30:1991;1059-1062.
40. Shelley A.M., Grochowski S., Lieberman J.A., Javitt D.C. Premature disinhibition of P3 generation in schizophrenia. Biol Psychiatry. 39:1996;714-719.
41. Shepherd M., Watt D., Falloon I., Smeeton N. The natural history of schizophrenia A five-year follow-up study of outcome and prediction in a representative sample of schizophrenics . Psychol Med Monogr Suppl. 15:1989;1-46.
42. Simson R., Ritter W., Vaughan H.G. Jr. Effects of expectation on negative potentials during visual processing. Electroencephalogr Clin Neurophysiol. 62:1985;25-31.
43. Spring B., Lemon M., Fergeson P. Vulnerabilities to schizophrenia Information-processing markers . Straube E.R., Hahlweg K. Schizophrenia Concepts, Vulnerability, and Intervention . 1990;97-114 Springer-Verlag, Berlin.
44. Strandburg R.J., Marsh J.T., Brown W.S., Asarnow R.F., Guthrie D., Higa J., et al. Reduced attention-related negative potentials in schizophrenic adults. Psychophysiology. 31:1994;272-281.
45. Tsuang M., Woolson R., Fleming J. Long-term outcome of major psychoses I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions . Arch Gen Psychiatry. 36:1979;1295-1301.
46. Ventura J., Nuechterlein K.H., Hardesty J.P., Gitlin M. Life events and schizophrenic relapse after withdrawal of medication. Br J Psychiatry. 161:1992;615-620.
47. Zubin J., Steinhauer S. How to break the logjam in schizophrenia A look beyond genetics . J Nerv Ment Dis. 169:1981;477-492.